Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer

Gynecological Endocrinology

Volumn 22, Issue 5, 2006, Pages 235-238

  Doldi, Nicola ^a   Persico, Paola ^a   Di Sebastiano, Francesca ^a   Marsiglio, Elena ^a   Ferrari, Augusto ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Gonadotropin releasing hormone antagonist; In vitro fertilization; Metformin; Polycystic ovary syndrome

Indexed keywords

CETRORELIX; GONADORELIN ANTAGONIST; METFORMIN; RECOMBINANT CHORIONIC GONADOTROPIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; ECHOGRAPHY; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

CHORIONIC GONADOTROPIN; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; METFORMIN; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 33745356083     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/14767050600761893     Document Type: Article

References (19)

1. Adams J, Poison DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293:355-359.
2. Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies Gynecol Endocrinol 1987;1:235-245.
3. Velazquez E, Acosta A, Mendoza SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 1997;90:392-395.
4. Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 2001;75:310-315.
5. Morin-Papunen LC, Koivunen RM, Ruokonen A, Martikainen HK. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril 1998;69:691-696.
6. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998;338:1876-1880.
7. Ibanez L, Valls C, Potau N, Marcos MV, de Zegher F, Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. J Clin Endocrinol Metab 2000;85:3526-3530.
8. Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril 2000;73:1149-1154.
9. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85:2767-2774.
10. Seale FG, Robinson RD, Neal GS. Association of metformin and pregnancy in the polycystic ovary syndrome. A report of three cases. J Reprod Med 2000;45:507-510.
11. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A, Devroey P. Comparison of different doses of gonadotropin-releasing hormone antagonist cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 1997;67:917-922.
12. Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moredu L, Nicollet B, Zorn JR, Bouchard P, Frydman R. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 2000;73:314-320.
13. Hwang JL, Huang LW, Hsieh BC, Tsai YL, Huang SC, Chen CY, Hsieh ML, Chen PH, Lin YH. Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles. Hum Reprod 2003;18:45-49.
14. Homburg R. The management of infertility associated with polycystic ovary syndrome. Reprod Biol Endocrinol 2003;1:109.
15. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
16. Elkind-Hirsch KE, Webster BW, Brown CP, Vernon MW. Concurrent ganirelix and follitropin-β therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome. Fertil Steril 2003;79:603-607.
17. De Leo V, la Marca A, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 2003;24:633-667.
18. Palomba S, Orio F Jr, Nardo LG, Falbo A, Russo T, Corea D, Doldo P, Lombardi G, Tolino A, Colao A, et al. Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab 2004;89:4801-4809.
19. Berker B, Emral R, Demirel C, Corapcioglu D, Unlu C, Kose K. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy. Gynecol Endocrinol 2004;19:125-133.